Skip to main content

Table 1 Clinical data at the time point of renal biopsy

From: March hemoglobinuria progressed to acute kidney injury after kendo practice: a case report

Parameter

Value (reference range)

Parameter

Value (reference range)

Parameter

Value (reference range)

Hematological

 

Blood biochemistry

 

Immunological test

 

White blood cell count, /μL

8100 (4000-8000)

Total protein, g/dL

7.0 (6.7-8.3)

CH50, IU/mL

77 (32-49)

Hemoglobin, g/dL

15.6 (14-18)

Albumin, g/dL

4.7 (3.9-4.9)

C3, mg/dL

128 (65-135)

Platelets, ×104/μL

14.1 (15-35)

Blood urea nitrogen, mg/dL

30 (8-22)

C4, mg/dL

28 (13-35)

Reticulocyte, %

1.3 (0.2-2.8)

Creatinine, mg/dL

2.98 (0.61-1.04)

IgG, mg/dL

867 (870-1700)

  

eGFR, mL/min/1.73m2

27 (>60)

IgA, mg/dL

197 (110-410)

Coagulation test

 

Cystatin C, mg/dL

1.35 (0.63-0.95)

IgM, mg/dL

56 (35-220)

within normal range

 

Uric acid, mg/dL

12.7 (2-7)

  
  

Creatinine kinase, mg/dL

127 (60-287)

Antinuclear antibody, IU/mL

<40 (<40)

Urinalysis

 

Sodium, mmol/L

139 (138-146)

MPO-ANCA, IU/mL

<1.0 (0-3.5)

pH

5.0 (4.5-8.0)

Potassium, mmol/L

4.4 (3.6-4.9)

PR3-ANCA, IU/mL

<1.0 (0-3.5)

Specific gravity

1.011 (1.005-1.025)

Chloride, mmol/L

99 (99-109)

anti-GBM, U/mL

<2.0 (0-3)

Protein urea, g/g creatinine

<0.15 (<0.15)

Calcium, mg/dL

9.2 (8.7-10.3)

ASO, IU/mL

<10 (0-239)

Red Blood Cell, /HPF

1~4 (<5)

Glucose, mg/dL

98 (70-109)

ASK 

<20 (<20)

White Blood Cell, /HPF

5~9 (<5)

Bilirubin totally, mg/dL

2.9 (0.2-1.3)

cryoglobulin

negative

U-NAG, IU/L

7.4 (0.7-11.2)

Bilirubin direct, mg/dL

0.9 (0-0.3)

  

U-β2MG, μg/L

10 (0-230)

AST, IU/L

14 (13-33)

Haptoglobin, mg/dL

183 (19-170)

U-α1MG, mg/L

2.3 (1-15.5)

ALT, IU/L

11 (8-42)

DAT

negative

L-FABP, μg/g creatinine

0.81 (0-8.4)

LDH, IU/L

313 (124-222)

  
  

Total cholesterol, mg/dL

139 (128-219)

  

Blood gas analysis

 

LDL cholesterol, mg/dL

82 (70-139)

  

pH

7.313 (6-8)

Triglyceride, mg/dL

83 (30-149)

  

HCO3, mmol/L

25.9 (0-99.9)

C-reactive protein, mg/dL

1.9 (0-0.3)

  

Base excess, mmol/L

-1.1 (-99~99)

HbA1c, %

5.3 (4.6-6.2)

  

Hemolysis test

     

Ham test

negative

    

erythrocyte fragility test

negative

    
  1. U-NAG Urinary N-acetyl-β-D-Glucosaminidase, U-β2MG Urinary beta2-microglobulin, U-α1MG Urinary alpha1-microglobulin, eGFR Estimated glomerular filtration rate, L-FABP, L-type fatty acid-binding protein, AST Aspartate amino transferase, ALT Alanine aminotransferase, LDH Lactate dehydrogenase, LDL Low density lipoprotein, HbA1c Hemoglobin A1c, Ig Immunoglobulin, MPO Myeloperoxidase, PR3 Proteinase, ANCA Anti-neutrophil cytoplasmic antibody, GBM Glomerular basement membrane, ASO Anti-streptolysin, ASK Anti-streptokinase antibody, DAT Direct antiglobulin test